First TAVR System Approved for Severe Aortic Regurgitation
(MedPage Today) -- The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, device maker JenaValve Technology announced. This approval makes Trilogy the only transcatheter aortic...
Source
MedPage Today
Opens original article in a new tab
